Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Rifapentine for the treatment of pulmonary tuberculosis.

Munsiff SS, Kambili C, Ahuja SD.

Clin Infect Dis. 2006 Dec 1;43(11):1468-75. Epub 2006 Oct 24. Review.

2.

Rifapentine.

Jarvis B, Lamb HM.

Drugs. 1998 Oct;56(4):607-16; discussion 617. Review. Erratum in: Drugs 1999 Apr;57(4):506.

PMID:
9806107
3.

Rifapentine: its role in the treatment of tuberculosis.

Temple ME, Nahata MC.

Ann Pharmacother. 1999 Nov;33(11):1203-10. Review.

PMID:
10573321
4.

Rifapentine vs. rifampicin for the treatment of pulmonary tuberculosis: a systematic review.

Gao XF, Li J, Yang ZW, Li YP.

Int J Tuberc Lung Dis. 2009 Jul;13(7):810-9. Review.

PMID:
19555529
5.

Treatment of latent tuberculosis infection.

Parekh MJ, Schluger NW.

Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20. Review.

PMID:
24056289
6.

New approaches to the treatment of latent tuberculosis.

Sterling TR.

Semin Respir Crit Care Med. 2008 Oct;29(5):532-41. doi: 10.1055/s-0028-1085704. Epub 2008 Sep 22. Review.

PMID:
18810686
7.

An update on the use of rifapentine for tuberculosis therapy.

Chan JG, Bai X, Traini D.

Expert Opin Drug Deliv. 2014 Mar;11(3):421-31. doi: 10.1517/17425247.2014.877886. Epub 2014 Jan 8. Review.

PMID:
24397259
8.

Antituberculosis drugs and hepatotoxicity.

Yew WW, Leung CC.

Respirology. 2006 Nov;11(6):699-707. Review.

PMID:
17052297
9.

New drugs for tuberculosis treatment.

Sánchez F, López Colomés JL, Villarino E, Grosset J.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:47-56. doi: 10.1016/S0213-005X(11)70018-0. Review.

PMID:
21420567
10.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
11.

Management of active tuberculosis.

Potter B, Rindfleisch K, Kraus CK.

Am Fam Physician. 2005 Dec 1;72(11):2225-32. Review.

12.

Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence.

Vidal JS, Silva MT, Sanchez MN.

Rev Soc Bras Med Trop. 2015 Sep-Oct;48(5):507-13. doi: 10.1590/0037-8682-0156-2014. Review.

13.

Old and new drugs for the treatment of tuberculosis in children.

Donald PR, Schaaf HS.

Paediatr Respir Rev. 2007 Jun;8(2):134-41. Epub 2007 Jun 5. Review.

PMID:
17574157
14.

[Clinical practice guidelines from the Andalusian Society of Infectious Diseases (SAEI) for the treatment of tuberculosis].

Domínguez-Castellano A, Del Arco A, Canueto-Quintero J, Rivero-Román A, Kindelán JM, Creagh R, Díez-García F.

Enferm Infecc Microbiol Clin. 2007 Oct;25(8):519-34. Review. Spanish.

PMID:
17915111
15.

Fluoroquinolones for the treatment of pulmonary tuberculosis.

Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F.

Drugs. 2007;67(14):2077-99. Review.

PMID:
17883288
16.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.

17.

Treatment of latent tuberculosis infection.

Vernon A.

Semin Respir Crit Care Med. 2013 Feb;34(1):67-86. doi: 10.1055/s-0032-1333544. Epub 2013 Mar 4. Review.

PMID:
23460007
18.

Pulmonary tuberculosis.

Hirsch CS, Johnson JL, Ellner JJ.

Curr Opin Pulm Med. 1999 May;5(3):143-50. Review.

PMID:
10228738
19.

[Tuberculosis treatment in 2007].

Tattevin P.

Med Mal Infect. 2007 Oct;37(10):617-28. Epub 2007 Jun 14. Review. French.

PMID:
17572033
20.

Basic concepts in the treatment of tuberculosis.

Swaminathan S.

Indian J Pediatr. 2002 Nov;69 Suppl 1:S44-9. Review.

PMID:
12501925
Items per page

Supplemental Content

Write to the Help Desk